Azalium Pharmaceutical Private Limited has established a major presence across acute and chronic therapeutic areas. Explore our primary therapy segments below to see our product listings and molecules.
Targeted, high-potency formulations engineered to combat modern microbial challenges and support infection control.
Neuro-protective, mood-stabilizing, and cognitive support therapies addressing acute and chronic neurological conditions.
Comprehensive hormonal, prenatal, and therapeutic solutions supporting every stage of women’s wellness.
Scientifically balanced nutraceuticals and micronutrient therapies to boost immunity and metabolic health.
Fast-acting and sustained-release analgesics and muscle relaxants designed for effective recovery and comfort.
We are investing heavily in specialty therapeutics that address unmet medical needs. Our pipeline focuses on drug-device combinations, dermatology, and select central nervous system (CNS) treatments.
Azalium is a leading supplier of complex APIs to global pharmaceutical companies. Our API facilities are regularly inspected by major health authorities, ensuring absolute purity, stability, and regulatory compliance.
Our advanced biologics division is developing a robust portfolio of biosimilar molecules, aiming to make highly complex and expensive biological treatments affordable and accessible to patients worldwide.
Azalium formulates and manufactures products across diverse delivery systems meeting international regulatory standards.